BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 37463410)

  • 1. Autophagy Inhibition Increased Sensitivity of Pancreatic Cancer Cells to Carbon Ion Radiotherapy.
    Sudo M; Tsutsui H; Hayashi S; Yasuda K; Mitani K; Iwami N; Anzai M; Tsubouchi T; Ishida M; Satoi S; Kanai T; Hirono S; Hatano E; Fujimoto J
    Cell Physiol Biochem; 2023 Jul; 57(4):212-225. PubMed ID: 37463410
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Carbon Ion Radiotherapy
    Yamamoto N; Oshima T; Kawahara S; Takahashi D; Kamioka Y; Murakawa M; Katoh H; Ueno M; Morinaga S
    Anticancer Res; 2023 Feb; 43(2):809-815. PubMed ID: 36697091
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Carbon-Ion Radiotherapy Combined with Concurrent Chemotherapy for Locally Advanced Pancreatic Cancer: A Retrospective Case Series Analysis.
    Okamoto M; Shiba S; Kobayashi D; Miyasaka Y; Okazaki S; Shibuya K; Ohno T
    Cancers (Basel); 2023 May; 15(10):. PubMed ID: 37345195
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phase I/II trial evaluating concurrent carbon-ion radiotherapy plus chemotherapy for salvage treatment of locally recurrent nasopharyngeal carcinoma.
    Kong L; Gao J; Hu J; Hu W; Guan X; Lu R; Lu JJ
    Chin J Cancer; 2016 Dec; 35(1):101. PubMed ID: 28007028
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost-effectiveness of carbon-ion radiotherapy versus stereotactic body radiotherapy for non-small-cell lung cancer.
    Okazaki S; Shibuya K; Takura T; Miyasaka Y; Kawamura H; Ohno T
    Cancer Sci; 2022 Feb; 113(2):674-683. PubMed ID: 34820994
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Carbon ion radiotherapy triggers immunogenic cell death and sensitizes melanoma to anti-PD-1 therapy in mice.
    Zhou H; Tu C; Yang P; Li J; Kepp O; Li H; Zhang L; Zhang L; Zhao Y; Zhang T; Sheng C; Wang J
    Oncoimmunology; 2022; 11(1):2057892. PubMed ID: 35355680
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Conversion and validation of rectal constraints for prostate carcinoma receiving hypofractionated carbon-ion radiotherapy with a local effect model.
    Wang W; Li P; Sheng Y; Huang Z; Zhao J; Hong Z; Shahnazi K; Jiang GL; Zhang Q
    Radiat Oncol; 2021 Apr; 16(1):72. PubMed ID: 33849589
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Significance of PD-L1 expression in carbon-ion radiotherapy for uterine cervical adeno/adenosquamous carcinoma.
    Iijima M; Okonogi N; Nakajima NI; Morokoshi Y; Kanda H; Yamada T; Kobayashi Y; Banno K; Wakatsuki M; Yamada S; Kamada T; Aoki D; Hasegawa S
    J Gynecol Oncol; 2020 Mar; 31(2):e19. PubMed ID: 31912675
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FGFR Signaling as a Candidate Therapeutic Target for Cancers Resistant to Carbon Ion Radiotherapy.
    Darwis NDM; Nachankar A; Sasaki Y; Matsui T; Noda SE; Murata K; Tamaki T; Ando K; Okonogi N; Shiba S; Irie D; Kaminuma T; Kumazawa T; Anakura M; Yamashita S; Hirakawa T; Kakoti S; Hirota Y; Tokino T; Iwase A; Ohno T; Shibata A; Oike T; Nakano T
    Int J Mol Sci; 2019 Sep; 20(18):. PubMed ID: 31540114
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical outcomes of carbon-ion radiotherapy for patients with locoregionally recurrent nasopharyngeal carcinoma.
    Hu J; Huang Q; Gao J; Guan X; Hu W; Yang J; Qiu X; Chen M; Kong L; Lu JJ
    Cancer; 2020 Dec; 126(23):5173-5183. PubMed ID: 32931035
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunomodulatory effects of carbon ion radiotherapy in patients with localized prostate cancer.
    Hu W; Pei Y; Ning R; Li P; Zhang Z; Hong Z; Bao C; Guo X; Sun Y; Zhang Q
    J Cancer Res Clin Oncol; 2023 Jul; 149(8):4533-4545. PubMed ID: 36138265
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The relative biological effectiveness of carbon ion radiation therapy for early stage lung cancer.
    Jeong J; Taasti VT; Jackson A; Deasy JO
    Radiother Oncol; 2020 Dec; 153():265-271. PubMed ID: 32976878
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical results of carbon-ion radiotherapy for stage I non-small cell lung cancer with concomitant interstitial lung disease: a Japanese national registry study (J-CROS-LUNG).
    Okano N; Suefuji H; Nakajima M; Tokumaru S; Kubo N; Yoshida D; Suzuki O; Ishikawa H; Satouchi M; Nakayama H; Shioyama Y
    J Radiat Res; 2023 Jun; 64(Supplement_1):i2-i7. PubMed ID: 37036751
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of Oncologic Outcomes and Treatment-Related Toxicity of Carbon Ion Radiotherapy and En Bloc Resection for Sacral Chordoma.
    Yolcu YU; Zreik J; Wahood W; Bhatti AUR; Bydon M; Houdek MT; Rose PS; Mahajan A; Petersen IA; Haddock MG; Ahmed SK; Laack NN; Jethwa K; Jeans EB; Imai R; Yamada S; Foote RL
    JAMA Netw Open; 2022 Jan; 5(1):e2141927. PubMed ID: 34994795
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adaptive planning based on single beam optimization in passive scattering carbon ion radiotherapy for patients with pancreatic cancer.
    Li Y; Kubota Y; Okamoto M; Shiba S; Okazaki S; Matsui T; Tashiro M; Nakano T; Ohno T
    Radiat Oncol; 2021 Jun; 16(1):111. PubMed ID: 34147099
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carbon Ion Radiotherapy Acts as the Optimal Treatment Strategy for Unresectable Liver Cancer During the Coronavirus Disease 2019 Crisis.
    Li Z; Li Q; Wang X; Li S; Chen W; Jin X; Liu X; Dai Z; Liu X; Zheng X; Li P; Zhang H; Zhang Q; Luo H; Liu R
    Front Public Health; 2021; 9():767617. PubMed ID: 34957022
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro evaluation of photon and raster-scanned carbon ion radiotherapy in combination with gemcitabine in pancreatic cancer cell lines.
    El Shafie RA; Habermehl D; Rieken S; Mairani A; Orschiedt L; Brons S; Haberer T; Weber KJ; Debus J; Combs SE
    J Radiat Res; 2013 Jul; 54 Suppl 1(Suppl 1):i113-9. PubMed ID: 23824114
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Feasibility and Safety of Repeated Carbon Ion Radiotherapy for Locally Advanced Unresectable Pancreatic Cancer.
    Okamoto M; Shiba S; Okazaki S; Miyasaka Y; Shibuya K; Kiyohara H; Ohno T
    Cancers (Basel); 2021 Feb; 13(4):. PubMed ID: 33562274
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phase 1 trial of preoperative, short-course carbon-ion radiotherapy for patients with resectable pancreatic cancer.
    Shinoto M; Yamada S; Yasuda S; Imada H; Shioyama Y; Honda H; Kamada T; Tsujii H; Saisho H;
    Cancer; 2013 Jan; 119(1):45-51. PubMed ID: 22744973
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Carbon Ion Radiotherapy Evokes a Metabolic Reprogramming and Individualized Response in Prostate Cancer.
    Ning R; Pei Y; Li P; Hu W; Deng Y; Hong Z; Sun Y; Zhang Q; Guo X
    Front Public Health; 2021; 9():777160. PubMed ID: 34950631
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.